Depression Treatment

From the advanced search, you can use the IDs below to search within the topic "Depression Treatment" (whose ID is 7), by searching on (7/0) [cluster] (replacing the "7/0" with any cluster id below)

ID	Cluster Name Click to Search	Defining Terms
7/0	Depression Treatment sub-cluster 0	qol quality life patients scores symptoms depression questionnaire treatment health
7/1	Depression Treatment sub-cluster 1	ect suicide depression suicidal depressive patients ideation depressed electroconvulsive treatment
7/2	Depression Treatment sub-cluster 2	risperidone olanzapine clozapine haloperidol schizophrenia patients treatment symptoms scale antipsychotic
7/3	Depression Treatment sub-cluster 3	antipsychotic antipsychotics schizophrenia atypical treatment quetiapine patients symptoms clozapine risperidone
7/4	Depression Treatment sub-cluster 4	ptsd symptoms posttraumatic stress disorder depression traumatic treatment trauma veterans
7/5	Depression Treatment sub-cluster 5	alcohol treatment depression alcoholism alcoholics drinking patients alcoholic naltrexone placebo
7/6	Depression Treatment sub-cluster 6	ocd obsessive compulsive disorder treatment clomipramine patients symptoms scale depression
7/7	Depression Treatment sub-cluster 7	migraine headache placebo patients treatment headaches sumatriptan attacks pain efficacy
7/8	Depression Treatment sub-cluster 8	bipolar depression mania disorder manic depressive mood patients unipolar treatment
7/9	Depression Treatment sub-cluster 9	stroke patients depression outcome acute scale ischemic trials treatment score
7/10	Depression Treatment sub-cluster 10	epilepsy seizure seizures patients depression treatment placebo antiepileptic group partial
7/11	Depression Treatment sub-cluster 11	panic adhd disorder placebo treatment anxiety alprazolam depression patients attacks
7/12	Depression Treatment sub-cluster 12	coping depression patients depressive symptoms strategies anxiety group style treatment
7/13	Depression Treatment sub-cluster 13	dementia depression cognitive patients alzheimer symptoms caregiver scale depressive elderly
7/14	Depression Treatment sub-cluster 14	elderly depression depressive depressed patients treatment geriatric symptoms scale life
7/15	Depression Treatment sub-cluster 15	lithium manic depressive treatment depression patients bipolar mania carbonate psychosis
7/16	Depression Treatment sub-cluster 16	asthma inhaled patients placebo treatment symptoms group corticosteroids fev1 budesonide
7/17	Depression Treatment sub-cluster 17	acupuncture group treatment patients placebo pain groups trial sham controlled
7/18	Depression Treatment sub-cluster 18	psychotherapy group treatment depression therapy outcome patients interpersonal therapist alliance
7/19	Depression Treatment sub-cluster 19	paroxetine sertraline depression venlafaxine placebo treatment patients ham efficacy duloxetine
7/20	Depression Treatment sub-cluster 20	cost costs effectiveness treatment patients economic group therapy trial depression
7/21	Depression Treatment sub-cluster 21	fatigue depression cfs eating patients symptoms nervosa treatment bulimia binge
7/22	Depression Treatment sub-cluster 22	depression serotonin ssris reuptake ssri treatment antidepressants inhibitors antidepressant selective
7/23	Depression Treatment sub-cluster 23	ms sclerosis multiple patients disability edss depression placebo treatment trial
7/24	Depression Treatment sub-cluster 24	anxiety depression symptoms patients depressive scale treatment disorders scores disorder
7/25	Depression Treatment sub-cluster 25	hrqol sf-36 patients scores health quality life physical related score
7/26	Depression Treatment sub-cluster 26	sad depression seasonal light winter affective disorder patients depressive treatment
7/27	Depression Treatment sub-cluster 27	ad alzheimer donepezil patients cognitive disease placebo dementia depression treatment
7/28	Depression Treatment sub-cluster 28	depression postpartum depressive postnatal adolescents symptoms mothers adolescent women depressed
7/29	Depression Treatment sub-cluster 29	antidepressant antidepressants depression treatment depressive tricyclic patients depressed placebo response
7/30	Depression Treatment sub-cluster 30	bph prostatic symptom prostate urinary benign hyperplasia patients men placebo
7/31	Depression Treatment sub-cluster 31	pd parkinson levodopa patients depression disease motor symptoms updrs placebo
7/32	Depression Treatment sub-cluster 32	fluoxetine imipramine amitriptyline depression placebo treatment depressive patients blind depressed
7/33	Depression Treatment sub-cluster 33	schizophrenia symptoms negative patients depression psychotic positive scale treatment symptom
7/34	Depression Treatment sub-cluster 34	smoking cocaine nicotine treatment cessation abstinence methadone smokers placebo withdrawal
7/35	Depression Treatment sub-cluster 35	depression bdi screening beck inventory depressive patients scores symptoms scale
7/36	Depression Treatment sub-cluster 36	sexual erectile sildenafil ed dysfunction placebo treatment patients men group
7/37	Depression Treatment sub-cluster 37	stress depression events life depressive symptoms stressful anxiety patients depressed
7/38	Depression Treatment sub-cluster 38	illness depressive depression patients manic ill illnesses symptoms treatment depressed
7/39	Depression Treatment sub-cluster 39	diazepam insomnia benzodiazepine placebo anxiety benzodiazepines patients withdrawal treatment buspirone
7/40	Depression Treatment sub-cluster 40	depression care patients depressive primary treatment symptoms depressed physicians gps
7/41	Depression Treatment sub-cluster 41	rehabilitation fim outcome discharge patients admission outcomes functional stroke inpatient
7/42	Depression Treatment sub-cluster 42	nasal rhinitis allergic placebo symptoms patients treatment pollen immunotherapy symptom
7/43	Depression Treatment sub-cluster 43	cognitive depression therapy treatment patients cbt depressive symptoms impairment behavioral
7/44	Depression Treatment sub-cluster 44	depression cortisol dexamethasone dst depressed patients depressive endogenous suppression hpa
7/45	Depression Treatment sub-cluster 45	injury tbi traumatic outcome patients brain trauma head group score
7/46	Depression Treatment sub-cluster 46	relapse remission depression treatment patients depressive placebo therapy symptoms group
7/47	Depression Treatment sub-cluster 47	item scale depression scores scales validity rating questionnaire patients symptoms
7/48	Depression Treatment sub-cluster 48	incontinence urinary bladder patients symptoms treatment placebo oab urgency group
7/49	Depression Treatment sub-cluster 49	schizophrenic neuroleptic patients schizophrenia symptoms schizophrenics neuroleptics treatment dyskinesia tardive
7/50	Depression Treatment sub-cluster 50	arthritis rheumatoid ra patients placebo treatment joint disease mtx group
7/51	Depression Treatment sub-cluster 51	analgesia morphine pain group epidural fentanyl bupivacaine patients postoperative analgesic
7/52	Depression Treatment sub-cluster 52	quality life patients depression treatment scores symptoms questionnaire health group
7/53	Depression Treatment sub-cluster 53	copd pulmonary patients obstructive placebo fev1 chronic exacerbations inhaled group
7/54	Depression Treatment sub-cluster 54	knee osteoarthritis oa pain patients womac group placebo hip score
7/55	Depression Treatment sub-cluster 55	compliance cpap sleep osa treatment patients sleepiness apnea obstructive group
7/56	Depression Treatment sub-cluster 56	depression rtms depressed patients prefrontal magnetic transcranial depressive stimulation frontal
7/57	Depression Treatment sub-cluster 57	nausea vomiting ondansetron placebo patients metoclopramide group antiemetic ponv emesis
7/58	Depression Treatment sub-cluster 58	botulinum toxin spasticity btx patients treatment placebo dystonia baclofen improvement
7/59	Depression Treatment sub-cluster 59	heart failure patients depression chf hf placebo group treatment congestive
7/60	Depression Treatment sub-cluster 60	ibs bowel irritable symptoms constipation patients placebo syndrome treatment group
7/61	Depression Treatment sub-cluster 61	psychological distress depression symptoms patients anxiety symptom treatment group scale
7/62	Depression Treatment sub-cluster 62	angina st placebo depression patients nifedipine group segment pectoris treatment
7/63	Depression Treatment sub-cluster 63	personality depression depressive patients traits scores borderline disorder inventory anxiety
7/64	Depression Treatment sub-cluster 64	reliability validity scale questionnaire scores patients scales retest assessment version
7/65	Depression Treatment sub-cluster 65	depression depressive major depressed disorder patients symptoms dsm episode disorders
7/66	Depression Treatment sub-cluster 66	hypertension patients placebo bp antihypertensive treatment group pressure mg hypertensive
7/67	Depression Treatment sub-cluster 67	interventions group adherence patients control trial randomized treatment participants depression
7/68	Depression Treatment sub-cluster 68	ulcer patients placebo reflux pylori treatment symptoms dyspepsia group healing
7/69	Depression Treatment sub-cluster 69	cholesterol patients placebo ldl group statin treatment lipid statins mg
7/70	Depression Treatment sub-cluster 70	psychiatric symptoms depression patients treatment disorders depressive disorder anxiety inpatients
7/71	Depression Treatment sub-cluster 71	interferon placebo treatment patients ifn hepatitis acyclovir group therapy ribavirin
7/72	Depression Treatment sub-cluster 72	ci trials rr patients placebo treatment randomized group controlled meta
7/73	Depression Treatment sub-cluster 73	sedation propofol group midazolam patients anesthesia anaesthesia groups recovery fentanyl
7/74	Depression Treatment sub-cluster 74	trials cochrane controlled studies randomised review search quality data criteria
7/75	Depression Treatment sub-cluster 75	placebo diclofenac naproxen patients pain aspirin mg blind nsaids ibuprofen
7/76	Depression Treatment sub-cluster 76	depression resistant treatment malaria patients resistance falciparum therapy trd group
7/77	Depression Treatment sub-cluster 77	depression depressive symptoms depressed social older ces women risk health
7/78	Depression Treatment sub-cluster 78	training group biofeedback treatment gait patients groups relaxation control improvement
7/79	Depression Treatment sub-cluster 79	scale scales mmpi depression rating scores mmpi-2 validity inventory personality
7/80	Depression Treatment sub-cluster 80	pain patients back treatment group disability chronic depression placebo symptoms
7/81	Depression Treatment sub-cluster 81	plaque group periodontal gingival periodontitis placebo treatment probing misoprostol oral
7/82	Depression Treatment sub-cluster 82	decision treatment making decisions patients clinical information patient trials group
7/83	Depression Treatment sub-cluster 83	atrial patients af fibrillation group rhythm placebo amiodarone ventricular sinus
7/84	Depression Treatment sub-cluster 84	gh group growth hormone patients treatment groups placebo therapy depression
7/85	Depression Treatment sub-cluster 85	trial randomized controlled clinical randomised patients treatment randomization design consent
7/86	Depression Treatment sub-cluster 86	patients icu apache mortality sepsis group score ventilation intensive ii
7/87	Depression Treatment sub-cluster 87	heparin bleeding patients group warfarin placebo venous treatment dvt thrombosis
7/88	Depression Treatment sub-cluster 88	trial clinical treatment design randomized treatments designs studies outcome statistical
7/89	Depression Treatment sub-cluster 89	lidocaine group pain injection patients placebo block injections anesthesia groups
7/90	Depression Treatment sub-cluster 90	tinnitus treatment tmd orthodontic patients group hearing temporomandibular symptoms occlusal
7/91	Depression Treatment sub-cluster 91	psoriasis topical treatment cream patients placebo dermatitis acne weeks efficacy
7/92	Depression Treatment sub-cluster 92	women placebo premenstrual symptoms group treatment patients menopausal cycles postmenopausal
7/93	Depression Treatment sub-cluster 93	placebo blind double controlled trial patients treatment group placebos randomized
7/94	Depression Treatment sub-cluster 94	laser group iop visual patients treatment glaucoma timolol acuity wound
7/95	Depression Treatment sub-cluster 95	patients group dialysis vitamin placebo nutritional hemodialysis iron treatment pancreatitis
7/96	Depression Treatment sub-cluster 96	depression depressed depressive treatment depressions patients states psychotic clinical childhood
7/97	Depression Treatment sub-cluster 97	depression spreading central depressant depressants nervous cortical synaptic shock depressed
7/98	Depression Treatment sub-cluster 98	patients treatment group antibiotic placebo days antibiotics clinical efficacy therapy
7/99	Depression Treatment sub-cluster 99	score scoring patients clinical system outcome assessment group severity scale